Loading chat...
FL S0876
Bill
AI Summary
- Health insurers and health maintenance organizations in Florida would be prohibited from refusing to contract with or denying coverage for providers administering Chimeric Antigen Receptor T-cell (CAR-T) therapy, a type of cancer treatment
- Eligible providers must qualify as certified health care facilities under the FDA procedure for the CAR-T product license and must already be included in the insurer's provider network for other services
- Applies to individual health insurance policies, group health insurance policies, and health maintenance organization contracts issued, delivered, or renewed on or after January 1, 2026
- Creates three new Florida statutes (ss. 627.64198, 627.6614, and 641.31078) to cover the different types of health coverage arrangements
- Sponsored by Senator Berman, with an effective date of January 1, 2026
Legislative Description
Chimeric Antigen Receptor T-cell Therapy
Last Action
Died in Banking and Insurance
6/16/2025
Full Bill Text
No bill text available